Order Article Reprints

Chen Y-S, Huang K-H, Wang P-M, Chuang C-H, Yong C-C, Liu Y-W, Huang P-Y, Yao C-C, Lin Y-P, Tsai M-C. The Impact of Direct-Acting Antiviral Therapy on the Risk of Recurrence after Curative Resection in Patients with Hepatitis-C-Virus-Related Early Stage Hepatocellular Carcinoma. Medicina. 2022; 58(2):259. https://doi.org/10.3390/medicina58020259

Chen, Yu-Syuan, Kuo-Hsuan Huang, Pei-Ming Wang, Ching-Hui Chuang, Chee-Chien Yong, Yueh-Wei Liu, Pao-Yuan Huang, Chih-Chien Yao, Yen-Po Lin, and Ming-Chao Tsai. 2022. "The Impact of Direct-Acting Antiviral Therapy on the Risk of Recurrence after Curative Resection in Patients with Hepatitis-C-Virus-Related Early Stage Hepatocellular Carcinoma" Medicina 58, no. 2: 259. https://doi.org/10.3390/medicina58020259

Chen, Y.-S., Huang, K.-H., Wang, P.-M., Chuang, C.-H., Yong, C.-C., Liu, Y.-W., Huang, P.-Y., Yao, C.-C., Lin, Y.-P., & Tsai, M.-C. (2022). The Impact of Direct-Acting Antiviral Therapy on the Risk of Recurrence after Curative Resection in Patients with Hepatitis-C-Virus-Related Early Stage Hepatocellular Carcinoma. Medicina, 58(2), 259. https://doi.org/10.3390/medicina58020259